A cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say - statnews.com
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say the company's cautious culture is to blame.
Comments